Thus, we propose that decreased NO bioavailability, as seen in many forms of chronic kidney diseases, induces intrarenal RAS activation by stimulating CD-renin production, resulting in increased sodium reabsorption, hypertension, and kidney injury. This evidence concerns the gene REN and chronic kidney disease.